Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Conditions
- Colorectal Carcinoma
- Endometrial Carcinoma
- Melanoma
- Neuroblastoma
- Ovarian Carcinoma
- Pancreatic Ductal Adenocarcinoma
- Recurrent Desmoid Fibromatosis
- Recurrent Ewing Sarcoma
- Recurrent Hepatoblastoma
- Recurrent Hepatocellular Carcinoma
- Recurrent Malignant Solid Neoplasm
- Recurrent Non-Hodgkin Lymphoma
- Recurrent Osteosarcoma
- Refractory Desmoid Fibromatosis
- Refractory Ewing Sarcoma
- Refractory Hepatoblastoma
- Refractory Hepatocellular Carcinoma
- Refractory Malignant Solid Neoplasm
- Refractory Non-Hodgkin Lymphoma
- Refractory Osteosarcoma
- Solid Pseudopapillary Neoplasm of the Pancreas
- Wilms Tumor
Interventions
- PROCEDURE: Biospecimen Collection
- PROCEDURE: Dual X-ray Absorptiometry
- DRUG: Tegavivint
- PROCEDURE: X-Ray Imaging
Sponsor
Children's Oncology Group
Collaborators